als_ely_facility

ALS Pharma quadruples Cambridgeshire testing facility in £2m expansion

pharmafile | September 12, 2016 | News story | Manufacturing and Production, Research and Development, Sales and Marketing ALS Pharmaceutical, Microbiology, expansion 

UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part of a £2 million-plus investment to grow its ability to keep up with increased testing demands.

The new laboratories (pictured) were officially opened at the beginning of the month, bringing more than 35 new staff to the company.

‘Our laboratory has experienced double-digit growth for the last five years, and we now perform more than 40,000 chemical and microbiological tests every month, helping to ensure medicines and cosmetics meet safety standards and their stated shelf-life,’ commented Sharon Hanly, general manager of ALS Pharmaceutical.

Advertisement

The company is part of the £700 million ALS Global company and offers a range of analytical testing services.

Matt Fellows

Related Content

f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its …

Recipharm to open largest Nordic GLP bioanalysis lab

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona …

china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in …

The Gateway to Local Adoption Series

Latest content